Contain your excitement because it's yet to be tested on humans. But it's "novel" and "oral".
Novel calpain inhibitor inhibits the progress of multiple sclerosis (MS) in an animal model 05 August 2008
Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis (MS) in an animal model. The agent, a novel calpain inhibitor, can be administered orally.
Calpains are a family of proteolytic enzymes naturally ...